Back
VYNE Therapeutics, Inc. Vs. Bruker Corp. Industry Stock Comparison
Buy
62
VYNE
VYNE Therapeutics, Inc.
Last Price:
$0.58
Seasonality Move:
-5.82%
Sell
29
BRKR
Bruker Corp.
Last Price:
$47.69
Seasonality Move:
4.48%
Buy
62
VYNE Therapeutics, Inc. (VYNE)
is a Buy
Is VYNE Therapeutics, Inc. a Buy, Sell or Hold?
-
The current VYNE Therapeutics, Inc. [VYNE] share price is $0.58. The Score for VYNE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
VYNE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Bruker Corp. (BRKR)
is a Sell
Is Bruker Corp. a Buy, Sell or Hold?
-
The current Bruker Corp. [BRKR] share price is $48.12. The Score for BRKR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYNE Stock Price Chart
What is VYNE Therapeutics, Inc.'s stock price today?
-
The VYNE Therapeutics, Inc. share price today is $0.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BRKR Stock Price Chart
What is Bruker Corp.'s stock price today?
-
The Bruker Corp. share price today is $48.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRKR is experiencing slight buying pressure.
VYNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 73.62 | Buy |
| Chaikin Money Flow: | 884187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.33 - 0.51) | Buy |
| Bollinger Bands (100): | (0.3 - 0.42) | Buy |
BRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 60.89 | Buy |
| Chaikin Money Flow: | 237020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.1 - 48.46) | Buy |
| Bollinger Bands (100): | (32.13 - 44.03) | Buy |
VYNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.44 | Buy |
| 50-day SMA: | 0.39 | Buy |
| 200-day SMA: | 0.85 | Sell |
| 8-day EMA: | 0.45 | Buy |
| 20-day EMA: | 0.26 | Buy |
| 50-day EMA: | 0.12 | Buy |
| 200-day EMA: | 0.03 | Buy |
BRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.39 | Buy |
| 20-day SMA: | 46.91 | Buy |
| 50-day SMA: | 43.15 | Buy |
| 200-day SMA: | 39.05 | Buy |
| 8-day EMA: | 47.02 | Buy |
| 20-day EMA: | 46.2 | Buy |
| 50-day EMA: | 43.5 | Buy |
| 200-day EMA: | 42.58 | Buy |
VYNE Therapeutics, Inc. Earnings Growth & VYNE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.36 per share, and a decrease next year of $0.21 per share.
Bruker Corp. Earnings Growth & BRKR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.27 per share.
VYNE Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bruker Corp. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||